From the Journals

ECT cost effective in treatment-resistant depression


 

FROM JAMA Psychiatry


Mr. Ross and his coauthors cited several limitations. One is that much of the input data used in the mathematical model is more than 10 years old. In addition, other novel interventions for treatment-resistant depression – such as repetitive transcranial magnetic stimulation – were not evaluated.

The study was supported by the Department of Veterans Affairs Health Services Research & Development Services. The study authors had no conflicts of interest to report.

SOURCE: Ross EL et al. JAMA Psychiatry. 2018 May 9. doi: 10.1001/jamapsychiatry.2018.0768..

Pages

Recommended Reading

VIDEO: Novel postpartum depression drug effective in phase 3 trial
MDedge Family Medicine
Commentary: Shifting the care delivery paradigm to diabetes-depression collaborative care models
MDedge Family Medicine
U.S. youth suicide prevention saved nearly 900 lives
MDedge Family Medicine
MDedge Daily News: How to handle opioid constipation
MDedge Family Medicine
Off-label prescribing of SGAs in children varies by diagnosis
MDedge Family Medicine
Comorbidities provide possible path to schizophrenia subtypes
MDedge Family Medicine
Universal depression screening for adolescents not without controversy
MDedge Family Medicine
U.S. public largely ignores firearm access and suicide completion link
MDedge Family Medicine
First, marijuana. Are magic mushrooms next?
MDedge Family Medicine
Suicide prevention gets ‘standard care’ recommendations
MDedge Family Medicine